Learn to Customize Your Own Options Trading Strategy
This guide will help you evaluate and analyze your trading plan to create a custom options trading strategy tailored to your risk profile and market outlook. Learn how to take your trading to the next level.
Download your FREE Options Strategy Guide Today!
Lee Kalowski, insider at Bicycle Therapeutics
Lee Kalowski Insider Alerts

Get notified the next time Lee Kalowski buys or sells Bicycle Therapeutics stock. Enter your email address below to get our daily insider buying and selling report.

Lee Kalowski Insider Information

Lee Kalowski, MBA has served as our Chief Financial Officer since July 2017 and as our President since January 2019. Prior to joining us, from September 2014 until September 2016, Mr. Kalowski served as the Chief Financial Officer and from September 2016 until May 2017, served as the consulting Chief Financial/Business Officer of Tokai Pharmaceuticals, Inc., a biopharmaceutical company. Prior to Tokai, from June 2010 to September 2014, Mr. Kalowski served in global biotechnology equity research at Credit Suisse, where he covered companies in the biopharmaceutical industry as a Senior Analyst from May 2011 until September 2014 and as an Associate from June 2010 until May 2011. Mr. Kalowski received a B.A. in biology and economics from Union College and an MBA from The Wharton School of the University of Pennsylvania. Provided by Tagnifi.

What is Lee Kalowski's net worth?

The estimated net worth of Lee Kalowski is at least $28,990.50 as of August 27th, 2021. Mr. Kalowski owns 550 shares of Bicycle Therapeutics stock worth more than $28,991 as of December 5th. This net worth evaluation does not reflect any other assets that Mr. Kalowski may own. Learn More.

What is Lee Kalowski's salary?

As the CFO of Bicycle Therapeutics plc, Mr. Kalowski earned a total compensation package of $1,141,835.00 in 2020. Mr. Kalowski earned a salary of $463,500.00, options awards of $385,704.00, non-equity compensation of $292,631.00, and no other miscellaneous compensation.

How do I contact Lee Kalowski?

The corporate mailing address for Mr. Kalowski and other Bicycle Therapeutics executives is B900 BABRAHAM RESEARCH CAMPUS, CAMBRIDGE X0, CB22 3AT. Bicycle Therapeutics can also be reached via phone at 441223261503.

Has Lee Kalowski been buying or selling shares of Bicycle Therapeutics?

Lee Kalowski has not been actively trading shares of Bicycle Therapeutics within the last three months. Most recently, Lee Kalowski sold 7,950 shares of the business's stock in a transaction on Friday, August 27th. The shares were sold at an average price of $35.15, for a transaction totalling $279,442.50. Following the completion of the sale, the chief financial officer now directly owns 550 shares of the company's stock, valued at $19,332.50.

Who are Bicycle Therapeutics' active insiders?

Bicycle Therapeutics' insider roster includes Stephen Alexander (SVP), Kate Bingham (Director), Nigel Crockett (Insider), Lee Kalowski (CFO), Nicholas Keen (Insider), Kevin Lee (CEO), and Pierre Legault (Director).

Are insiders buying or selling shares of Bicycle Therapeutics?

In the last twelve months, insiders at the sold shares 32 times. They sold a total of 335,765 shares worth more than $10,907,357.52. The most recent insider tranaction occured on October, 18th when CEO Kevin Lee sold 49 shares worth more than $2,940.00. Insiders at Bicycle Therapeutics own 17.9 % of the company.

Information on this page was last updated on 10/18/2021.

Lee Kalowski Insider Trading History at Bicycle Therapeutics

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
8/27/2021Sell7,950$35.15$279,442.50550View SEC Filing Icon  
8/23/2021Sell7,500$33.02$247,650.007,500View SEC Filing Icon  
7/29/2021Sell12,500$31.51$393,875.0012,500View SEC Filing Icon  
1/19/2021Sell15,000$30.00$450,000.0015,000View SEC Filing Icon  
12/1/2020Sell7,500$22.50$168,750.007,500View SEC Filing Icon  
11/27/2020Sell530$20.00$10,600.00530View SEC Filing Icon  
11/25/2020Sell9,781$20.07$196,304.6717,189View SEC Filing Icon  
11/23/2020Sell17,189$19.83$340,857.8717,189View SEC Filing Icon  
See Full Table

Lee Kalowski Buying and Selling Activity at Bicycle Therapeutics

This chart shows Lee Kalowski's buying and selling at Bicycle Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Bicycle Therapeutics Company Overview

Bicycle Therapeutics logo
Bicycle Therapeutics Plc is a clinical-stage biopharmaceutical company, which engages in developing a novel class of medicines, which the company refers to as bicycles, for diseases that are underserved by existing therapeutics. The firm utilizes its novel and proprietary phage display screening platform to identify bicycles. Its portfolio includes internal product candidates that are directed to oncology applications. The company was founded by Gregory Winter, John Tite, and Christian Heinis in 2009 and is headquartered in Cambridge, the United Kingdom.
Read More

Today's Range

Now: $52.71
Low: $52.08
High: $58.30

50 Day Range

MA: $53.77
Low: $39.07
High: $61.14

2 Week Range

Now: $52.71
Low: $17.95
High: $62.08

Volume

234,038 shs

Average Volume

214,490 shs

Market Capitalization

$1.55 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A
Learn to Customize Your Own Options Trading Strategy
This guide will help you evaluate and analyze your trading plan to create a custom options trading strategy tailored to your risk profile and market outlook. Learn how to take your trading to the next level.
Download your FREE Options Strategy Guide Today!